2x founder

Diego Rey

CEO, Gemini Therapeutics

Co-founder

Endpoint Health· Winter 2019 🇺🇸 San Francisco, California, United States

in LinkedIn 𝕏 @diegoarey

2025Chief Executive Officer· Gemini Therapeutics

Founder · since 2010

Company

Gemini Therapeutics

Role

Chief Executive Officer

current

Stage

—

no public source

Raised

—

no public source

Based

San Francisco, California, United States

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Endpoint Health

Precision-first therapies

Winter 2019

Experience

Career

Gemini Therapeutics
Chief Executive Officer · San Francisco, California, United States · 2025 – Present
2025
Endpoint Ventures
Angel investing · San Francisco Bay Area · 2018 – Present
2018
ENDPOINT HEALTH
Co-founder
Co-Founder & Chief Scientific Officer · Palo Alto, CA · 2018 – 2024
2018
Y Combinator
Expert/Part time Partner · San Francisco Bay Area · 2018 – 2021
2018
Y Combinator
Visiting Partner · San Francisco Bay Area · 2017 – 2018
2017
Roche Molecular Systems
Head of Research, GeneWEAVE Division of Roche Molecular Systems · Los Gatos, CA · 2015 – 2017
2015
GeneWEAVE
Co-founder
Co-Founder & Chief Technology Officer · Los Gatos, CA · 2010 – 2015
2010
Batt Research Group
Graduate Research Assistant · Ithaca, New York Area · 2004 – 2010
2004

Bio

Diego Rey, born in Bariloche, Argentina and now based in San Francisco, holds a BS (UCSB) in electrical engineering and PhD (Cornell) in biomedical engineering minoring in applied engineering physics and biophysics. He co-founded GeneWEAVE (acquired by Roche) and Endpoint Health (W19) developing rapid bacterial detection and immune disease therapeutics. Diego was the first bio Visiting Partner at YC. He Angel invests and serves on Cornell advisory councils.